The Toronto Blue Jays enter the 2026 season facing a familiar yet increasingly urgent question, as injuries begin to test the depth of their starting rotation and force the front office to evaluate potential external solutions.

With multiple arms currently on the Injured List, including Jose Berrios, Trey Yesavage, and Shane Bieber, the situation may not yet be classified as a long-term crisis, but it has certainly raised concerns about sustainability.

Even if those pitchers are expected to return, the reality of a long MLB season means that relying solely on internal options could prove risky, particularly for a team with postseason aspirations.

That uncertainty has opened the door to speculation, and one of the more aggressive scenarios proposed involves a blockbuster deal with the New York Mets.

According to a mock trade floated by Ryan Shea of SI.com, the Blue Jays could acquire Kodai Senga in exchange for a substantial package of top prospects.

The proposed deal would see Toronto receive Senga, while New York would land JoJo Parker, Ricky Tiedemann, and Johnny King, forming a package that immediately raises eyebrows due to its sheer value.

At first glance, the structure of this trade reflects a classic win-now versus future-bet scenario, where Toronto would be sacrificing long-term upside for immediate rotation stability.

Senga, now 33 years old, represents a proven major league arm with a track record of effectiveness, having posted a solid 3.00 ERA across 54 career starts since arriving in MLB.

His consistency when healthy makes him an appealing target for any contender, particularly one seeking a mid-rotation or even top-end starter capable of handling high-pressure innings.

However, the key phrase in that evaluation remains “when healthy,” as Senga’s career has also been marked by periodic injury concerns that complicate his overall value.

While he appears to be in good form early in the 2026 campaign, teams must weigh not only his current production but also the likelihood of maintaining that level over a full season.

For the Blue Jays, this creates a classic risk-reward equation, where the upside of adding a reliable starter must be balanced against the cost of losing elite young talent.

Among the names included in the proposed package, Tiedemann stands out as a particularly significant piece, widely regarded as one of the organization’s most promising pitching prospects.

Standing at 6-foot-4 with a deceptive delivery and high strikeout potential, Tiedemann has long been viewed as a future cornerstone of Toronto’s rotation.

His development trajectory suggests that he could make a meaningful impact at the major league level in the near future, making his inclusion in any trade a major decision point.

Similarly, Parker represents another critical asset, currently ranked as the Blue Jays’ No. 2 overall prospect and projected to play a key role in the team’s long-term infield plans.

Parting with both Tiedemann and Parker would not simply be a trade, but a strategic pivot away from building around homegrown talent toward a more immediate competitive window.

This is where the debate becomes particularly intense, as fans and analysts weigh the urgency of the present against the promise of the future.

On one hand, adding Senga could provide the stability needed to navigate a challenging stretch of the season, especially if injuries persist or internal options fail to deliver.

On the other hand, sacrificing multiple high-upside prospects for a pitcher with durability concerns introduces a level of risk that cannot be ignored.

From the Mets’ perspective, the situation is equally complex, as their current rotation appears to rely heavily on Senga’s presence and production.

Trading him would create an immediate void, potentially weakening a staff that already depends on his ability to anchor key matchups.

However, if the organization believes that its competitive timeline aligns more closely with long-term development, acquiring a package of premium prospects could be an attractive proposition.

It is also worth noting that Senga’s name has surfaced in trade rumors before, particularly during the offseason, though no deal ultimately materialized at that time.

That history suggests that while the Mets may be open to exploring options, they are unlikely to move him without receiving a return that significantly enhances their future outlook.

Another factor to consider is Senga’s contract, a five-year, $75 million deal that, while reasonable by today’s standards, still represents a financial commitment that must be factored into any trade discussions.

For Toronto, absorbing that contract would be manageable, but it further underscores the importance of ensuring that the acquisition delivers consistent value.

The broader context of this potential deal also reflects a growing trend in MLB, where teams are increasingly willing to make bold moves to address immediate needs, even at the cost of future assets.

Yet, history has shown that such decisions can yield vastly different outcomes, depending on how well the acquired player performs and how the traded prospects develop.

If Senga were to remain healthy and perform at a high level, the trade could be viewed as a masterstroke that solidifies Toronto’s rotation and boosts its playoff chances.

Conversely, if injuries resurface or performance declines, the loss of Tiedemann and Parker could haunt the organization for years to come.

As for the Mets, the decision ultimately hinges on their confidence in their current roster and their willingness to embrace a longer-term rebuilding or retooling strategy.

If they believe that Senga is essential to their immediate competitiveness, a trade becomes far less likely, regardless of the potential return.

However, should circumstances change, whether due to performance trends or broader organizational priorities, the idea of moving Senga could quickly regain momentum.

In the end, this proposed trade encapsulates the delicate balance that every MLB front office must navigate between present ambition and future sustainability.

For the Blue Jays, the question is not simply whether they need a starting pitcher, but whether the cost of acquiring one aligns with their vision for the franchise.

And for now, while the idea of adding Senga is undeniably appealing, the price may simply be too high to justify the gamble.